Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth.
Yao N, Wang CR, Liu MQ, Li YJ, Chen WM, Li ZQ, Qi Q, Lu JJ, Fan CL, Chen MF, Qi M, Li XB, Hong J, Zhang DM, Ye WC.
Yao N, et al. Among authors: qi m, qi q.
Signal Transduct Target Ther. 2020 Oct 9;5(1):214. doi: 10.1038/s41392-020-00251-2.
Signal Transduct Target Ther. 2020.
PMID: 33033232
Free PMC article.